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The hepatocyte growth factor/scatter factor (HGFISF) receptor consists of an a- and a/%subumt. whtch are dertved from a single-cham precursor 
by endoproteolyttc processing. The precursor is not proteolyttcally processed in LoVo colon carcmoma cells The uncleaved receptor immunopu- 
rtfied from the cells was cleaved in vttro by furm. Furthermore, the HGFlSF receptor was proteolytically processed m LoVo cells transfected wtth 
furm cDNA. These results Indicate that furin is a processing endoprotease for the HGFlSF receptor. Tyrosine autophosphorylation of the uncleaved 
receptor was induced by HGF/SF, and the growth of the cells expressing the uncleaved receptor was sttmulated by HGF/SF, Indicating that the 
proteolytic processmg of the receptor IS not essential for the signal transduction of HGF/SF. 
Hepatocyte growth factor; Scatter factor: c-Met receptor; Proteolytic processing; Furin 
1. INTRODUCTION 
Hepatocyte growth factor/scatter factor (HGF/SF) 
[1,2] is a heparin-binding glycoprotein with a broad 
spectrum of biological activities. It stimulates the 
growth of endothelial cells, melanocytes, and epithelial 
cells including hepatocytes [3-71. It also dissociates ep- 
ithelial cell colonies into individual cells by causing a 
breakdown of intercellular junctions and stimulates the 
motility of epithelial cells [8,9]. Furthermore, it inhibits 
the growth of some tumor cell lines [lo]. 
The HGF/SF receptor has been identified as the c-met 
proto-oncogene product [l 11. It belongs to the receptor 
tyrosine kinase family [12] and consists of a 50 kDa 
a-subunit and a 145 kDa P-subunit, which are linked by 
a disulfide bond [13,14]. The a-subunit and the N-termi- 
nal region of the P-subunit are extracellular and the 
C-terminal tyrosine kinase domain of the p-subunit is 
cytoplasmic [ 12,131. 
The mature 190 kDa heterodimeric HGF/SF receptor 
is produced from a 170 kDa single-chain precursor by 
proteolytic processing and terminal glycosylation [15]. 
There is a tetrabasic sequence, Arg-Lys-Lys-Arg, in the 
extracellular domain of the receptor [12], and, like the 
cleavage site of the insulin receptor [16,17], this region 
has been considered to be a proteolytic processing site 
[13]. As Arg-X-Arg/Lys-Arg is a consensus sequence 
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required for cleavage by furin [18], it is possible that 
furin is a processing protease for the HGF/SF receptor. 
Furin is a mammalian homolog of the yeast Kex2 pro- 
tease [19.20]. It is expressed in all tissues and cell lines 
tested [21,22]. and is considered to be a processing pro- 
tease for a variety of protein precursors with Arg-X- 
Arg/Lys-Arg sequences at the cleavage sites, such as 
those for growth factors, serum proteases, receptors, 
and viral glycoproteins [18]. Some of them have been 
reported to be cleaved by furin [23331]. 
Mondino et al. reported that the HGF/SF receptor in 
the LoVo human colon carcinoma cell line is not prote- 
olytically processed but terminally glycosylated and 
transported to the cell surface [32]. They also found that 
the coding-region of the HGF/SF receptor of LoVo cells 
was not mutated and the uncleaved receptor was 
cleaved by mild trypsin digestion to generate 01- and 
P-subunits of the correct size [32]. They therefore sug- 
gested that the processing endoprotease for the HGFI 
SF receptor is lost in LoVo cells [32]. 
In this study, using the uncleaved HGFlSF receptor 
of LoVo cells, we showed that the HGF/SF receptor is 
proteolytically processed by furin in vitro and in living 
cells. We also examined the effect of the proteolytic 
processing of the HGF/SF receptor on the signal 
transduction of HGF/SF. 
2. MATERIALS AND METHODS 
2 I. Materials 
Reagents were obtamed as follows: Na[“51] and [a-‘2P]dCTP from 
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Amrrsham Internattonal; Iodobeads from Pierce Chemtcal Co.. Gcn- 
ettcin (G418) from Gtbco Laboratories. anti-phosphotyrosme mono- 
clonal anttbody PY20 from ICN ImmunoBtologicals; anti-HGF/SF 
receptor polyclonal antibody from Santa Cruz Biotechnology Inc. and 
protein A-Srpharose from Pharmacta LKB Btotechnology Inc. Re- 
combmant human HGFlSF was provided by the Research Center. 
Mitsubisht Kasa Co. [33]. C-termmally truncated soluble furm was 
purtfied from the conditioned medium of the Chinese hamster ovary 
cell hne stably rxpressmg mutant furm (4704) as described prevtously 
[34] To construct the furm expresston vector pCMVFur, a mouse 
furm cDNA fragment covermg the entire coding sequence [‘I] was 
mierted downstream of the cytomegalovtrus promoter of pRcICMV 
(Invitrogen). Anti-HGF/SF receptor anttserum was prepared by im- 
munizing a rabbit wtth the chemically synthesized C-terminal 28 
ammo acid peptide of the human HGF/SF receptor conJugated to 
keyhole limpet hemocyanm (Calbiochcm Co ) usmg succimmidyl4-(p- 
maletmidophrnyl)butyrate (Pterce Chemtcal Co I. 
Subconfluent cells were detached from a 90-mm dash using phos- 
phate-buffered saline contaunng 0.01% EDTA, recovered by centrifu- 
gatton. and resuspended m 0 5 ml phosphate-buffered saline contain- 
mg 0.49 mM MgCI, and 0.68 mM CaCl, The suspended cells were 
iodmated with 0 5 mC1 Na[“‘I] using Iodobeads, lysed. and tm- 
munoprectpttated wtth antt-HGF/SF receptor antibody (2 pg) as de- 
scribed prevtously [35] The tmmunoprecipttate was assayed for in 
vitro cleavage by furm or separated by sodtum dodecyl sulfate-poly- 
acrylamtde gel electrophorests (SDS-PAGE) (7% polyacrylamtde). 
The HGFiSF receptor has detected by autoradiography. 
The iodmated~uncleaved HGF/SF receptor of LoVo cells uhtch 
bound to the anti-HGFISF receptor antibody coupled to protein A- 
Sepharose beads. was incubated with 0 025 to 0.4 units/ml soluble 
fur-m m 25 ~1 I-(2-hydroxyethyl)-I -ptperazmeethan\ulfonic acid/ 
NaOH (pH 7 0) contannng 0 5% Trtton X-100 and I mM CaCIZ for 
5 h at 37°C. The HGF/SF receptor was analyzed by SDS-PAGE (7% 
polyacrylamtdc). followed by autoradtography. 
LoVo cells uere provided by the Japanese Cancer Research Re- 
sources Bank and cultured m Ham’s F-12 medtum contammg 10% 
fetal calf strum Cells (I x I Oh) were transfected with 2Opg pCMVFur 
as descrtbed prevtously [36] and cultured m the presence of I mglml 
G418. Three weeks later. G418-resistant colonies uere selected and 
expanded. For control. pRc/CMV was trdnsfected Instead of 
pCMVFur and a cell line was obtained (neo cells). 
Cellular total RNA was prepared by the procedure descrtbed by 
Chomczynski and Sacchi [37]. Ftfteen mtcrograms of the RNA was 
denatured by formaldehyde. electrophoresed on a 1% agarose gel. and 
transferred to a nylon membrane (Btodyne). The 0.9 kbp BumHI- 
Brrr>lHI fragment of the mouse furm cDNA [‘I] was labeled with 
[a-“P]dCTP by the random primer labehng method [38] and used as 
a hybridization probe. Hybrtdizatton and washmg were carrted out 
according to the method of Alwme et al. [39]. 
2.6. Intm~rrtohk~tttrtg 
Confluent cells m a 90-mm dash were Incubated with 1 nM HGF/SF 
for 5 mm at 37°C. The cells were lysed and tmmunoprectpttated with 
anti-HGF/SF receptor antibody as described above. The immunopre- 
ctpitate vvas separated by SDS-PAGE (6% polyacrylannde) under 
reducing condtttons. Immunoblottmg with anti-phosphotyrosme anti- 
body and anti-HGF/SF receptor anttserum was performed as de- 
scrtbed previously [35]. 
2.7. Cell grorrth c~sa~ 
Cells (I x lOi) were plated on a 6-well plate and Incubated wtthout 
26 
or wtth 0 2 nM HGF/SF for 6 days The medtum was changed at day 
3 to supplement HGF/SF. The cells were trypsmized and counted 
using a hemocytometer. 
3. RESULTS 
3.1. Ckuvage qf the HGFISF rrccytor h~>,fi~irl in vitro 
First. we examined whether purified furin cleaved the 
immunopurified uncleaved HGF/SF receptor (~190”‘) 
of LoVo cells in vitro. The cell surface of LoVo cells was 
iodinated using Iodobeads. The cells were lysed and 
immunoprecipitated by anti-HGF/SF receptor anti- 
body. The immunoprecipitate was incubated with vari- 
ous concentrations of purified C-terminally truncated 
soluble furin. and analyzed by SDS-PAGE under reduc- 
ing conditions. The HGF/SF receptor was uncleaved in 
LoVo cells (Fig. 1, lane 1). Furin dose-dependently 
cleaved the p190NC to generate the heterodimer of the 
correct size (~50” and ~149) (Fig. 1. lane 326). 
3.2. Clrmugt~ qf tlw HGFISF rtwptor hy jirritl in living 
cells 
Northern blot analysis revealed that furin mRNA of 
the correct size (4.0 kb) was expressed in LoVo cells 
(Fig. 2). However. the in vitro experiment suggested 
that furin is a processing protease for the HGF/SF re- 
ceptor (Fig. 1). Thus. it is possible that active furin is 
not produced in the cells. To examine whether ~190~’ 
is processed by furin in living cells, we transfected the 
furin cDNA expression vector into LoVo cells. G418- 
resistant clones were screened by Northern blot analysis 
and two clones (Furl and Fur2) stably expressing the 
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Fig. 1. Proteolytic processing of the uncleaved HGF/SF receptor by 
furm in vitro. The cell surface of LoVo cells were iodinated and the 
cell lysate was immunoprecipitated by antt-HGFISF receptor antt- 
body. The immunoprectpttate absorbed to protem A-Sepharose beads 
were incubated without (lane 1) or wtth 0 025 (lane 2). 0 05 (lane 3). 
0.1 (lane 3). 0.2 (lane 5). and 0 4 umts/ml (lane 6) soluble furm. then 
analyzed by SDS-PAGE under reducmg conditions. The HGFlSF 
receptor was detected by autoradiography The molecular mass stand- 
ards were myosm (212 kDa). a,-macroglobulm (170 kDa). p-galacto- 
stdase (I 16 kDa). transferrm (76 kDa), and glutamtc dehydrogenase 
(53 kDa) 
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Fig. 2. Northern blot analysis of the RNA from the LoVo cells trans- 
fected with the furin cDNA. Total RNA (15 mg) from LoVo, neo, 
Furl, and Fur? cells were hybridized with mouse furm cDNA. White 
and black arrows mdlcate the endogenous and exogenous furin 
mRNAs, respectively. 
furin mRNA were obtained (Fig. 2). The exogenous 
furin mRNA was smaller than the endogenous mRNA 
because the expression vector did not cover the entire 
3’-non coding region of furin mRNA. The HGFlSF 
receptor in these clones and the control neo cells were 
analyzed by cell surface iodination and immunoprecipi- 
tation with anti-HGFISF receptor antibody. In Furl 
and Fur2 cells, p190NC was proteolytically processed to 
the heterodimer consisting of the ~50” and ~149 sub- 
units linked by a disulfide bond (Fig. 3). A small 
amount of p190NC was detected in Fur2 cells (Fig. 3). 
This could be due to low levels of furin expression, 
because its mRNA was expressed at much lower levels 
in Fur2 than in Furl cells (Fig. 2). This proteolytic 
processing did not occur in neo cells (Fig. 3). 
3.3. HGFISF-induced tyrosine autophosphorylation of 
the cleaved and uncleaved HGFISF receptor 
Binding of HGFlSF to its receptor induces rapid ty- 
rosine phosphorylation of the receptor in HGFISF-re- 
sponsible cells [11,35,40]. Mark et al. reported that the 
uncleaved HGF/SF receptor binds HGF/SF with an 
affinity similar to that of the cleaved receptor [41]. We 
examined whether proteolytic processing of the receptor 
was required for ligand-dependent tyrosine phosphoryl- 
ation. Control neo cells, Furl, and Fur2 cells were incu- 
bated with HGFISF, lysed, and immunoprecipitated 
with anti-HGF/SF receptor antibody. The immunopre- 
cipitates were immunoblotted with anti-phosphoty- 
rosine antibody or anti-HGF/SF receptor antiserum. 
The tyrosine phosphorylation of not only the cleaved 
receptor of Furl and Fur2 cells but also the uncleaved 
receptor of control neo cells was induced by HGF/SF 
(Fig. 4A), whereas the amount of the HGFlSF receptor 
was unchanged (Fig. 4B). 
3.4. The effect of HGFISF on the growth of LoVo cells 
expressing the cleaved or uncleaved HGFISF recep- 
tor 
We then examined the effect of HGFISF on the 
growth of LoVo cells expressing the cleaved or un- 
cleaved HGFISF receptor. Control neo cells, Fur 1, and 
Fur2 cells were cultured in the presence or absence of 
HGF/SF for 6 days and the cells were counted. The 
numbers of not only the cells expressing the cleaved 
receptor (Furl and Fur2 cells) but also those expressing 
the uncleaved receptor (neo cells) were increased by 
HGFlSF (1.5 to 2-fold of those of untreated cells), 
although the growth rates of the untreated cells were 
different among the clones (Fig. 5). None of the clones 
exhibited scattered morphology after exposure to HGFI 
SF (not shown). These results indicate that the prote- 
olytic processing of the HGFISF receptor is not essen- 
tial for the biological signal transduction of HGF/SF. 
4. DISCUSSION 
The HGF/SF receptor has a tetrabasic sequence at 
the extracelluIar domain and has been thought to be 
cleaved at this site [13], as is the insulin receptor 116,171. 
Recently, Mark et al. reported that none of the HGFlSF 
receptor mutants with a single amino acid replacement 
of Arg, Lys, or Arg at the fourth, second, or first residue 
upstream of the putative cleavage site, were proteolyti- 
Waf 
212 - 
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4 p190NC 
Mllp145p 
76 - 
53 - 
Fig. 3. Proteolytx processing of the HGFlSF receptor in the LoVo 
cells transfected with furin cDNA . The surfaces of neo, Furl, and 
Fur3 cells were lodmated and the cell lysates were immunoprecipitated 
with antl-HGF/SF receptor antibody. The immunoprecipitates were 
analyzed by SDS-PAGE under non-reducing (NR) or reducing (R) 
conditions, and the HGFiSF receptor was detected by autoradiogra- 
phy. 
27 
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Fig. 4. HGF/SF-induced tyrosme phosphorylatton of the cleaved and 
unclea\ed HGFKF receptor Neo. Furl. and Fur? cells were incu- 
bated wtthout (-) or wrth (+) 1 nM HGF/SF for 5 min. Iysed, and 
tmmunoprectpitated with anti-HGF/SF receptor antibody. The im- 
munoprectpttates were separated by SDS-PAGE under reducing con- 
dtttons and tmmunoblotted with anti-phosphotyrosme antibody (A) 
or anti-HGF/SF receptor antiserum (B). The 170 kDa protein 
(p17Or”) detected in (B) is the HGF/SF receptor precursor [15]. 
tally processed when their cDNAs were transfected into 
a fetal kidney cell line, and they suggested that the proc- 
essing endoprotease for the HGF/SF receptor is fur-in 
or a furin-like molecule [41] because the sequence Arg- 
X-Arg/Lys-Arg is the recognition sequence of furin [IS]. 
In this study. we showed that furin cleaves the HGF/SF 
receptor in vitro and in living cells. using LoVo cells in 
which the HGF/SF receptor is not cleaved. This is the 
direct evidence that furin is a processing endoprotease 
for the HGF/SF receptor. 
Furin is a member of the mammalian endoprotease 
family homologous to the yeast Kex2 protease [42]. 
Among the members of the family, PC2 and PCl/PC3 
are expressed only in neuroendocrine tissues [22] and 
PC4 is expressed only in the testis [43]. On the other 
hand. PACE4 [44] and PC6 [45] as well as furin [21.22] 
are ubiquitously expressed in various tissues. So, the 
possibility that PACE4 and/or PC6 are also responsible 
for the proteolytic processing of the HGF/SF receptor 
can not be excluded. 
In LoVo cells. furin mRNA of the correct size was 
expressed at a level similar to those of other cell lines 
in which the HGF/SF receptor is cleaved (not shown). 
The HGF/SF receptor was cleaved in LoVo cells trans- 
fected with furin cDNA. Thus. active furin is not pro- 
duced in the parental LoVo cells. A mutation in the 
furin gene may result in a defect of active furin in the 
cells. 
Mondino et al. reported that the uncleaved HGF/SF 
receptor in LoVo cells is constitutively phosphorylated 
on tyrosine [32]. We also observed this (not shown). 
However, the uncleaved HGF/SF receptor in control 
neo cells was not tyrosine-phosphorylated in the ab- 
sence of a ligand. Thus, the constitutive tyrosine phos- 
phorylation of the HGF/SF receptor in parental LoVo 
cells may not be due to the loss of the proteolytic proc- 
essing. 
The tyrosine phosphorylation of not only the cleaved 
HGF/SF receptor of Furl and Fur2 cells. but also the 
uncleaved receptor of neo cells, was induced by HGFI 
SF. HGF/SF also stimulated the growth of neo cells as 
well as Furl and Fur2 cells. Although we did not deter- 
mine the ligand-binding affinity of the uncleaved HGFI 
SF receptor in this study, it should not be drastically 
different from that of the cleaved receptor, because the 
sub-nanomolar (0.2 nM) HGF/SF. which is required for 
the maximal activity through the cleaved receptor [335], 
was also effective in stimulating the growth of neo cells 
in which the HGF/SF receptor was not cleaved. Mark 
et al. reported that the HGF/SF receptor mutants which 
were resistant to proteolytic processing bound HGF/SF 
with an affinity similar to that of the cleaved receptor 
(& 0.2 nM) [41]. Thus, the proteolytic processing of the 
HGFBF receptor is not essential for the biological sig- 
nal transduction of HGF/SF. Further investigation is 
q untreated 
n treated with HGF/SF 
T 
neo Furl Fur2 
Fig. 5. Effect of HGF/SF on the growth of LoVo cells expressing the 
cleaved or uncleaved HGF/SF receptor. Neo, Furl, and Fur?: cells 
(1 x IO”) were cultured without (hatched bars) or with 0.2 nM HGFi 
SF (black bars) for 6 days, and the cells were counted Each value 
represents the mean ? SD. (n = 3). 
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required to elucidate the biological significance of the 
proteolytic processing of the HGF/SF receptor. 
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